These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Quantitative histological change of myelinated nerve fibers and its significance. (II) In SMON(subacute-myelo-optico-neuropathy)]. Matsuoka Y, Mukoyama M, Takayanagi T, Sobue I. Rinsho Shinkeigaku; 1977 May; 17(5):310-5. PubMed ID: 560277 [No Abstract] [Full Text] [Related]
24. [Relationship between infection and subacute myelo-optico-neuropathy with abdominal symptoms (SMON) in the prevalent district. 1. Relationship between disease outbreak and the result of the examination of drinking water in the Ibara District, Okayama Prefecture (epidemiological study of SMON. 2)]. Ogata M, Jitsunari F, Shimada Y. Nihon Densenbyo Gakkai Zasshi; 1969 Aug; 43(5):113-9. PubMed ID: 4981516 [No Abstract] [Full Text] [Related]
25. [Neuropathology of subacute myelo-optico-neuropathy, (SMON)]. Shiraki H, Oda M. Saishin Igaku; 1969 Dec; 24(12):2479-509. PubMed ID: 5363408 [No Abstract] [Full Text] [Related]
26. Subacute myelo-optico-neuropathy, a new neurological disease prevailing in Japan. Kono R. Jpn J Med Sci Biol; 1971 Aug; 24(4):195-216. PubMed ID: 4944758 [No Abstract] [Full Text] [Related]
27. [Epidemiological studies on subacute myelo-optico neuropathy (SMON) in the town of Yubara, Japan. 3]. Aoyama H, Oira M, Ota T, Yoshioka S, Yoshida T. Nihon Eiseigaku Zasshi; 1970 Dec; 25(5):468-71. PubMed ID: 4251106 [No Abstract] [Full Text] [Related]
29. [Epidemiologic investigation on the etiology of subacute myelo-optic-neuropathy]. Kono R. Saishin Igaku; 1971 Oct; 26(10):1875-83. PubMed ID: 4942696 [No Abstract] [Full Text] [Related]
30. Is there SMON in India? Wadia NH. Neurol India; 1973 Sep; 21(3):95-103. PubMed ID: 4274127 [No Abstract] [Full Text] [Related]
31. [Pathohistology of the optic nerve in SMON (subacute myclo-optico neuropathy)]. Okuda K, Ueno H. Nihon Ganka Kiyo; 1970 Apr; 21(4):331-40. PubMed ID: 5463341 [No Abstract] [Full Text] [Related]
32. [Etiology of SMON (subacute myelo-optico neuropathy) theory of infection as its etiology]. Kono R. Saishin Igaku; 1969 Dec; 24(12):2403-6. PubMed ID: 5363398 [No Abstract] [Full Text] [Related]
33. [Subacute myelo-optico neuropathy (SMON) in Hokkaido, an epidemiological study. I (author's transl)]. Kasai M. Nihon Eiseigaku Zasshi; 1973 Aug; 28(3):315-23. PubMed ID: 4797519 [No Abstract] [Full Text] [Related]
34. [Epidemiological and clinical observations of SMON in Okayama]. Hiraki K, Iwasaki I, Uchida Y, Miyoshi I, Nanba M. Naika; 1969 Dec; 24(6):1139-46. PubMed ID: 5360079 [No Abstract] [Full Text] [Related]
35. Subacute myelo-optico-neuropathy (SMON)--neurotoxicity of clioquinols. Selby G. Proc Aust Assoc Neurol; 1973 Dec; 9():23-30. PubMed ID: 4268933 [No Abstract] [Full Text] [Related]
36. [Epidemiologic studies on subacute myelo-optico-neuropathy in Ibara and Yoshii areas]. Shimada Y. Saishin Igaku; 1969 Dec; 24(12):2424-30. PubMed ID: 5363401 [No Abstract] [Full Text] [Related]
37. [Japanese clinical statistical data of patients with subacute myelo-optico-neuropathy]. Ando K. Nihon Rinsho; 1992 Nov; 50 Suppl():139-46. PubMed ID: 1344342 [No Abstract] [Full Text] [Related]